NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Guangdong Hybribio Biotech Co.Ltd (SHE: 300639)

 
300639 Technical Analysis
5
As on 26th Jan 2026 300639 STOCK Price closed @ 7.25 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 5.93 & Strong Buy for SHORT-TERM with Stoploss of 6.18 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

300639STOCK Price

Open 6.16 Change Price %
High 7.25 1 Day 1.21 20.03
Low 6.12 1 Week 1.21 20.03
Close 7.25 1 Month 1.70 30.63
Volume 64212580 1 Year 0.52 7.73
52 Week High 7.25 | 52 Week Low 4.80
 
SHE China Most Active Stocks
002131 8.00 -4.76%
000630 7.55 10.06%
000981 4.74 -5.58%
000725 4.47 0.45%
002195 9.98 -5.04%
300058 20.74 0.92%
002202 28.40 -3.99%
000100 5.03 -0.40%
300017 13.78 20.03%
000620 3.40 -5.82%
 
SHE China Top Gainers Stocks
300463 14.20 20.03%
300017 13.78 20.03%
300639 7.25 20.03%
300871 32.62 20.01%
300139 52.90 20.01%
300391 0.92 19.48%
300461 32.32 18.30%
300482 25.56 16.23%
300209 7.23 15.50%
300837 66.00 15.36%
 
SHE China Top Losers Stocks
300117 0.43 -20.37%
300044 5.62 -14.33%
300503 61.70 -13.89%
300123 7.36 -13.41%
300421 30.20 -13.27%
300280 0.33 -13.16%
300672 135.96 -12.85%
300108 0.21 -12.50%
300208 0.28 -12.50%
300526 0.56 -12.50%
 
 
300639
Daily Charts
300639
Intraday Charts
Whats New @
Bazaartrend
300639
Free Analysis
 
300639 Important Levels Intraday
RESISTANCE9.43
RESISTANCE8.73
RESISTANCE8.30
RESISTANCE7.87
SUPPORT6.63
SUPPORT6.20
SUPPORT5.77
SUPPORT5.07
 
300639 Forecast January 2026
4th UP Forecast9.91
3rd UP Forecast9.06
2nd UP Forecast8.53
1st UP Forecast8
1st DOWN Forecast6.5
2nd DOWN Forecast5.97
3rd DOWN Forecast5.44
4th DOWN Forecast4.59
 
300639 Weekly Forecast
4th UP Forecast8.39
3rd UP Forecast8.02
2nd UP Forecast7.80
1st UP Forecast7.57
1st DOWN Forecast6.93
2nd DOWN Forecast6.70
3rd DOWN Forecast6.48
4th DOWN Forecast6.11
 
300639 Forecast2026
4th UP Forecast12.36
3rd UP Forecast10.72
2nd UP Forecast9.71
1st UP Forecast8.69
1st DOWN Forecast5.81
2nd DOWN Forecast4.79
3rd DOWN Forecast3.78
4th DOWN Forecast2.14
 
 
300639 Other Details
Segment EQ
Market Capital 8082085376.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
300639 Address
300639
 
300639 Latest News
 
Your Comments and Response on Guangdong Hybribio Biotech Co.Ltd
 
300639 Business Profile
Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, sale, marketing, and after-sales technical support services of in-vitro diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases, thalassemia, and prenatal neonatal. The company also offers female sample collection kits; DNA extraction kits, such as hepatitis B virus real-time PCR kits and thalassemia gene diagnostic kits; and devices/instruments, including flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems. Its products are used in the fields of clinical detection, large scale screening, research, and prenatal and neonatal management applications. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. is based in Sheung Wan, Hong Kong. Address: Bonham Trade Centre, Sheung Wan, Hong Kong
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service